Experience with eribulin in HR+/HER2- metastatic breast cancer, including a male

  1. Mar Muñoz Sánchez, M.D.
  2. Carmen Soriano Rodríguez, M.D.
  3. Molina Garrido, M.J.
  4. López-González, A.
  5. García-Palomo, A.
  6. López-González, L.
  7. Plata Fernández, M.Y.
  8. Caro, N.L.
  9. Rovira, P.S.
Journal:
Future Oncology

ISSN: 1744-8301,  1479-6694

Year of publication: 2018

Volume: 14

Issue: 7s

Pages: 5-12

Type: Article

DOI: 10.2217/FON-2017-0355 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus